RedHill Biopharma (RDHL) Loans - Gross (2011 - 2025)
RedHill Biopharma (RDHL) posted quarterly Loans - Gross of $19.2 million for Q4 2025, down 13.51% year-over-year from $22.2 million in Q4 2024, and down 13.76% quarter-over-quarter from $22.3 million in Q2 2025.
RedHill Biopharma (RDHL) Loans - Gross (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Loans - Gross for 15 consecutive years, with $19.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Loans - Gross fell 13.51% year-over-year to $19.2 million; the TTM figure through Dec 2025 stood at $19.2 million (down 13.51% YoY), while the FY2025 annual figure was $19.2 million, down 13.51% from the prior year.
- Loans - Gross fell to $19.2 million in Q4 2025 per RDHL's latest filing, from $22.3 million in the prior quarter.
- Across five years, Loans - Gross topped out at $197.5 million in Q4 2022 and bottomed at $19.2 million in Q4 2025.
- Historically, Loans - Gross has averaged $77.4 million across 5 years, with a median of $70.2 million in 2021.
- Annual changes were most pronounced in 2022 — Loans - Gross surged 114.54% — and 2023, when it plunged 89.88%.
- RedHill Biopharma's Loans - Gross stood at $92.0 million in 2021, then soared by 114.54% to $197.5 million in 2022, then slumped by 89.88% to $20.0 million in 2023, then advanced by 11.21% to $22.2 million in 2024, then declined by 13.51% to $19.2 million in 2025.
- Business Quant data shows RDHL's Loans - Gross at $19.2 million in Q4 2025, $22.3 million in Q2 2025, and $22.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Gross (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | 19.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.22 Mn |
| Jun 30, 2025 | 22.29 Mn |
| Dec 31, 2024 | 22.22 Mn |
| Jun 30, 2024 | 21.23 Mn |
| Dec 31, 2023 | 19.98 Mn |
| Jun 30, 2023 | 28.19 Mn |
| Mar 31, 2023 | 48.44 Mn |
| Dec 31, 2022 | 197.45 Mn |
| Sep 30, 2022 | 193.53 Mn |
| Mar 31, 2022 | 98.39 Mn |
| Dec 31, 2021 | 92.04 Mn |
| Sep 30, 2021 | 103.22 Mn |
| Jun 30, 2021 | 105.18 Mn |
| Mar 31, 2021 | 112.66 Mn |
| Dec 31, 2020 | 109.75 Mn |
| Sep 30, 2020 | 112.03 Mn |
| Jun 30, 2020 | 105.24 Mn |
| Mar 31, 2020 | 101.03 Mn |
| Dec 31, 2019 | 53.21 Mn |
| Sep 30, 2019 | 30.81 Mn |